Global Electroporation and Electrofusion Market 2024-2028

The electroporation and electrofusion market is forecasted to grow by USD 238.95 mn during 2023-2028, accelerating at a CAGR of 7.27% during the forecast period. The report on the electroporation and electrofusion market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	6.85%
CAGR	7.27%
Incremental Value	$238.95mn

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing incidence and prevalence of cancer, rising demand for biologics leading to increased demand for electroporation and electrofusion, and rising demand for monoclonal antibodies.

Technavio's electroporation and electrofusion market is segmented as below:

By Product

Consumables
Systems

By End-user

Industrial laboratories and CROs
Academic and government research institutes

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the high demand for biopharmaceuticals as one of the prime reasons driving the electroporation and electrofusion market growth during the next few years. Also, increasing demand for gene therapy and expanding field of regenerative medicine will lead to sizable demand in the market.

The report on the electroporation and electrofusion market covers the following areas:

Electroporation and electrofusion market sizing
Electroporation and electrofusion market forecast
Electroporation and electrofusion market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading electroporation and electrofusion market vendors that include AngioDynamics Inc., BEATIFIC Corp., BEX Co. Ltd., Bio Rad Laboratories Inc., Biogenuix Medsystems Pvt. Ltd., Celetrix LLC, Eppendorf SE, Gamma Biosciences, Gel Co. Inc, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, MoBiTec GmbH, Nepa Gene Co. Ltd., Richmond Scientific Ltd., Thermo Fisher Scientific Inc., and Westburg BV. Also, the electroporation and electrofusion market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR45361

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global electroporation and electrofusion market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global electroporation and electrofusion market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Consumables - Market size and forecast 2023-2028
Exhibit 34: Chart on Consumables - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Consumables - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Consumables - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
6.4 Systems - Market size and forecast 2023-2028
Exhibit 38: Chart on Systems - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Systems - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Systems - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Systems - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Industrial laboratories and CROs - Market size and forecast 2023-2028
Exhibit 48: Chart on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Industrial laboratories and CROs - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Industrial laboratories and CROs - Year-over-year growth 2023-2028 (%)
7.4 Academic and government research institutes - Market size and forecast 2023-2028
Exhibit 52: Chart on Academic and government research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Academic and government research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Academic and government research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Academic and government research institutes - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Exhibit 56: Market opportunity by End-user ($ million)
Exhibit 57: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Exhibit 91: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 AngioDynamics Inc.
Exhibit 107: AngioDynamics Inc. - Overview
Exhibit 108: AngioDynamics Inc. - Business segments
Exhibit 109: AngioDynamics Inc. - Key news
Exhibit 110: AngioDynamics Inc. - Key offerings
Exhibit 111: AngioDynamics Inc. - Segment focus
12.4 BEATIFIC Corp.
Exhibit 112: BEATIFIC Corp. - Overview
Exhibit 113: BEATIFIC Corp. - Product / Service
Exhibit 114: BEATIFIC Corp. - Key offerings
12.5 BEX Co. Ltd.
Exhibit 115: BEX Co. Ltd. - Overview
Exhibit 116: BEX Co. Ltd. - Product / Service
Exhibit 117: BEX Co. Ltd. - Key offerings
12.6 Bio Rad Laboratories Inc.
Exhibit 118: Bio Rad Laboratories Inc. - Overview
Exhibit 119: Bio Rad Laboratories Inc. - Business segments
Exhibit 120: Bio Rad Laboratories Inc. - Key news
Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
Exhibit 122: Bio Rad Laboratories Inc. - Segment focus
12.7 Biogenuix Medsystems Pvt. Ltd.
Exhibit 123: Biogenuix Medsystems Pvt. Ltd. - Overview
Exhibit 124: Biogenuix Medsystems Pvt. Ltd. - Product / Service
Exhibit 125: Biogenuix Medsystems Pvt. Ltd. - Key offerings
12.8 Celetrix LLC
Exhibit 126: Celetrix LLC - Overview
Exhibit 127: Celetrix LLC - Product / Service
Exhibit 128: Celetrix LLC - Key offerings
12.9 Eppendorf SE
Exhibit 129: Eppendorf SE - Overview
Exhibit 130: Eppendorf SE - Product / Service
Exhibit 131: Eppendorf SE - Key news
Exhibit 132: Eppendorf SE - Key offerings
12.10 Gamma Biosciences
Exhibit 133: Gamma Biosciences - Overview
Exhibit 134: Gamma Biosciences - Product / Service
Exhibit 135: Gamma Biosciences - Key offerings
12.11 Gel Co. Inc
Exhibit 136: Gel Co. Inc - Overview
Exhibit 137: Gel Co. Inc - Product / Service
Exhibit 138: Gel Co. Inc - Key offerings
12.12 Harvard Bioscience Inc.
Exhibit 139: Harvard Bioscience Inc. - Overview
Exhibit 140: Harvard Bioscience Inc. - Product / Service
Exhibit 141: Harvard Bioscience Inc. - Key offerings
12.13 Lonza Group Ltd.
Exhibit 142: Lonza Group Ltd. - Overview
Exhibit 143: Lonza Group Ltd. - Business segments
Exhibit 144: Lonza Group Ltd. - Key news
Exhibit 145: Lonza Group Ltd. - Key offerings
Exhibit 146: Lonza Group Ltd. - Segment focus
12.14 MaxCyte Inc.
Exhibit 147: MaxCyte Inc. - Overview
Exhibit 148: MaxCyte Inc. - Product / Service
Exhibit 149: MaxCyte Inc. - Key offerings
12.15 Miltenyi Biotec B.V. and Co. KG
Exhibit 150: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibit 151: Miltenyi Biotec B.V. and Co. KG - Product / Service
Exhibit 152: Miltenyi Biotec B.V. and Co. KG - Key offerings
12.16 Richmond Scientific Ltd.
Exhibit 153: Richmond Scientific Ltd. - Overview
Exhibit 154: Richmond Scientific Ltd. - Product / Service
Exhibit 155: Richmond Scientific Ltd. - Key offerings
12.17 Thermo Fisher Scientific Inc.
Exhibit 156: Thermo Fisher Scientific Inc. - Overview
Exhibit 157: Thermo Fisher Scientific Inc. - Business segments
Exhibit 158: Thermo Fisher Scientific Inc. - Key news
Exhibit 159: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 160: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 161: Inclusions checklist
Exhibit 162: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 163: Currency conversion rates for US$
13.4 Research methodology
Exhibit 164: Research methodology
Exhibit 165: Validation techniques employed for market sizing
Exhibit 166: Information sources
13.5 List of abbreviations
Exhibit 167: List of abbreviations